Genome-Wide Association Study of Short-Acting β(2)-Agonists. A Novel Genome-Wide Significant Locus on Chromosome 2 near ASB3

Rationale: β(2)-Agonists are the most common form of treatment of asthma, but there is significant variability in response to these medications. A significant proportion of this responsiveness may be heritable. Objectives: To investigate whether a genome-wide association study (GWAS) could identify...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Am J Respir Crit Care Med
Asıl Yazarlar: Israel, Elliot, Lasky-Su, Jessica, Markezich, Amy, Damask, Amy, Szefler, Stanley J., Schuemann, Brooke, Klanderman, Barbara, Sylvia, Jody, Kazani, Shamsah, Wu, Rongling, Martinez, Fernando, Boushey, Homer A., Chinchilli, Vernon M., Mauger, Dave, Weiss, Scott T., Tantisira, Kelan G.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Thoracic Society 2015
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4384768/
https://ncbi.nlm.nih.gov/pubmed/25562107
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1164/rccm.201408-1426OC
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller